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Abstract.  Transfection of chicken vinculin cDNA into 
two tumor cell lines expressing diminished levels of 
the endogenous protein,  brought about a drastic sup- 
pression of their tumorigenic ability. The SV-40-trans- 
formed Balb/e 3T3  line  (SV'F2) contains four times 
less vinculin than the parental  3T3 cells, and the rat 
adenocarcinoma BSp73ASML has no detectable vincu- 
lin.  Restoration of vinculin in these cells, up to the 
levels found in 3T3 cells, resulted in an apparent in- 
crease in substrate adhesiveness, a  decrease in the 
ability to grow in soft agar,  and suppression of their 
eapacity to develop tumors after injection into syn- 
geneic hosts or nude mice. These results suggest that 
vinculin,  a cytoplasmic component of cell-matrix and 
cell-cell adhesions,  may have a major suppressive 
effect on the transformed phenotype. 
M 
ALIGNANT transformation  is accompanied by di- 
verse cellular manifestations  including alterations 
in cell growth rate,  and major structural  changes 
affecting cell adhesion  and shape, locomotory activity, and 
cytoskeletal organization.  Morphological changes  are per- 
haps  among  the  most  conspicuous  features  of the  trans- 
formed phenotype in culture,  characterized  by rounded cell 
shape with poorly organized  microfilament  bundles (Weber 
et al.,  1974;  Pollack et al.,  1975) and aberrant adhesions 
(Ben-Ze'ev, 1985; Raz and Ben-Ze'ev, 1987). These changes 
are often correlated with a reduction in anchorage depen- 
dence  and  the  ability  of the cells  to  grow in  semi-solid 
medium such as soft agar or methyl  cellulose (Shin et al., 
1975). Furthermore, it has been shown that the deterioration 
or the microfilament  system in various malignant cells is ac- 
companied by altered  expression of microfilament-associ- 
ated proteins such as tropomyosin (Matsumura and Yamashiro- 
Matsumura,  1986), gelsolin  (Vandekerkhove et al.,  1989), 
and vineulin  (Raz and Geiger,  1982; Raz et al.,  1986). 
While the alterations in both the growth rate and cell struc- 
ture are inherent  features of the transformed phenotype, the 
causal relationships  between the two are unknown.  Are pri- 
mary changes in the adhesive properties of cells responsible 
for the loss of adhesion-dependent growth control, or does 
the altered regulation  of proliferation  lead to the acquisition 
of  the transformed morphology? In the present study we have 
directly approached this issue by selectively modulating  the 
levels of vinculin expression in tumor cells, and determined 
the effect of these changes  on the transformed phenotype. 
Vineulin  is a ubiquitous l17,000-D  protein which is as- 
sociated with adhesion plaques and cell-cell contacts,  at the 
termini of mierofilament  bundles (Geiger,  1979; Burridge et 
al.,  1988;  Geiger and  Ginsberg,  1991). Previous  studies 
provided much information  on the molecular properties of 
vineulin,  including its complete sequence (Cotou and Craig, 
1988; Price et ai., 1989), interactions  with other junctional 
proteins  (Geiger  and  Ginsberg,  1991), overall  molecular 
shape (Molony and Burridge,  1985), and mieroheterogeneity 
(Geiger,  1982). In addition,  it was recently shown that the 
expression of vineulin may be modulated in ceils by exposing 
them to different environmental  stimuli.  For example, fibro- 
blasts regulate the expression  of vinculin  RNA and protein 
in response to changes in cell density and substrate adhesive- 
ness (Ungar et al., 1986; Bendori et al., 1987); the synthesis 
and organization of vineulin in smooth muscle cells are both 
altered after transfer to tissue culture (Belkin et al.,  1988); 
vineulin expression is affected in the course of adipogenesis 
(Rodrfguez Fern(mdez and Ben-Ze'ev, 1989) and steroidogen- 
esis (Ben-Ze'ev and Amsterdam,  1987),  as well as during 
cell migration  in vivo (Zieske et al.,  1989). Moreover, vin- 
culin gene expression is rapidly, yet transiently,  stimulated 
in quiescent 3"I"3 cells upon growth activation by serum fac- 
tors (Ben-Ze'ev et al., 1990; Bellas et al., 1991) and in regen- 
erating  rat liver (Glfick et al.,  1992). Taken together,  these 
results  suggested that the regulation  of vinculin  expression 
may be involved in a wide variety of cellular processes, yet 
the eanse-and-effect  relationships  between vineulin regula- 
tion and these processes are still unclear (Ben-Ze'ev, 1991). 
To determine the effect of changes in vineulin  expression 
on tumorigenicity,  we transfected  chicken  vinculin  eDNA 
into two tumorigenic cell lines which either express vineulin 
at a reduced level, or no detectable vinculin.  These include 
an SV-40-transformed Balb/e 31"3 cell line, SVT2 (Aaronson 
and Todaro,  1968),  and a malignant  metastatic pancreatic 
adenocareinoma cell line, Bsp73ASML (ASML), which was 
derived from a spontaneous rat tumor (Matzku et al., 1983). 
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different levels of  the exogenous chicken vinculin cDNA and 
studied both their structure and behavior. We show here that 
the chicken vinculin  becomes incorporated into cell-substrate 
adhesion sites in the transfected cells. Furthermore, in both 
cell lines, expression of the foreign vinculin at high levels af- 
fected cell shape and dramatically suppressed the ability of 
the cells to form tumors and metastases when injected into 
experimental animals. This study provides direct evidence 
that modulation ofvinculin levels in malignant cells may rad- 
ically alter the transformed phenotype. 
Materials and Methods 
Cell Culture and Transfection 
Balb/c 3T3 clone A31 cells and SVT2 cells (Aaronson and Todaro,  1968) 
which are Balb/c 3T3  cells transformed by SV-40,  were grown in DME 
medium plus 10% calf serum (Gibco Laboratories, Grand Island, NY). The 
BSp73ASML clone 14 (ASML)  (Matzku et al.,  1983), which is a highly 
metastatic rat pancreatic adenocarcinoma cell line, was grown in RPMI 
medium plus  10% FCS (Biolah, Jerusalem, Israel). 
The ability of the tumor cells to grow  in soft agar was determined by 
seeding duplicates of 250,  103, and 104 cells per 35-ram diameter dish in 
0.85 ml of serum-containing medium and 0.3 % bacto-agar (Difco, Detroit, 
MI),  on top of a  solid layer of 2.5  ml of 0.5%  bacto-agar in the same 
medium.  The number of colonies containing >50 cells was determined 
microscopically after 5-7 d. 
The cells were transfected with a full-length chicken eDNA coding for 
vinculin, The construct used for transfection was obtained by tigating the 
EcoRI-BamHI fragment of the cVinl clone (Bendori et al.,  1989) contain- 
ing the 5" 1440 nucleetides, with the EcoRI-BamHI of cVin5 containing the 
3'-sequences,  including part  of the  noncoding  T-end.  Previous  studies 
confirmed that the product obtained after expression in eukaryotic cells was 
indistinguishable from chicken fibroblast vinculin (Bandori et al.,  1989). 
This construct was cloned into the EcoRI site of the polylinker of the pJ4fl 
expression vector provided by Dr. V. Rotter of our Institute (Shaulski et al., 
1991). The pJ4fl vector consists of the Mo-MuLV LTR promoter-enhancer 
sequence, the SV-40 small t-antigen intron, and the SV-40 large T polyade- 
nylation signal in the pBR322  plasmid.  The neomycin resistance (neo  r) 
gene, which was cotransfected with the pJ4fl construct containing the full- 
length chicken vinculin, was subcloned into the pSVL expression vector. 
Cells were transfected by the calcium phosphate precipitation method and 
colonies resistant to G418, 800 t~g/ml (Geneticin; Gibco Laboratories) for 
SVT2 cells, and 250 t~g/ml  for ASML cells were isolated. 
lmmunofluorescence and Electron Microscopy 
For immunofluorescence microscopy, cells were cultured on glass cover- 
slips,  fixed with  3 %  paraformaldehyde in PBS,  and permeabilized with 
0.5% Triton X-100. The paraformaldehyde-fixed ASML cells were sheared 
off the substrate with a jet of PBS, to expose the ventral cell membrane for 
better visualizing vinculin organization  (Avnur et al.,  1983).  The anti- 
chicken vinculin mAb and the broad-range monoclonal antivinculin anti- 
body were those used in a previous study (Bendori et al.,  1989; now avail- 
able from Sigma Chemical Co., St. Louis, MO). The second antibody was 
rhodamine-labeled goat anti-mouse IgG (Jackson Imrnunoresearch Labora- 
tories, "West Grove, PA). Actin filaments were stained with FITC-phalloidin 
(Sigma Chemical Co.). The cells were examined by epifluorescence with 
a Zeiss Axiophot microscope. 
For EM, cells were cultured on 35-mm tissue culture dishes. The cells 
were fixed in situ with 1% glutaraldehyde in 0.I  M cacodylate buffer, pH 
7.2, postfixed in 0.1% OsO4, flat embedded in Epon, and sectioned perpen- 
dicularly to the plane of the dish, Thin sections were stained with uranyt 
acetate and examined in a Philips transmission electron microscope,  CM 
12, at 100 KV. 
Cell b'~actionation, Immunoprecipitation,  and PAGE 
For immunoprecipitation, cells were labeled for 4  h  with 200/~C/ml of 
[asS] methionine and lysed in RIPA buffer (1% NP-40, 0.5% deoxycholate, 
0.1% SDS, 150 mM NaCI, 5 mM EDTA, 25 mM Tris, pH 8.0). The lysates 
were clarified by centrifugation at 15,000 g, and equal amounts of radioac- 
tive  proteins  (5  x  106 cpm)  were  incubated  with  the  chicken  vincu- 
lin-specific antibody. The immune complexes were precipitated with Staph- 
ylococcus aureus (The Enzyme Center, Boston, MA), and the precipitated 
proteins were separated by electrophoresis on 8 % polyacrylamide gels con- 
taining SDS. 
Two dimensional (2-D) gel electropboresis was performed as previously 
described (Ben-Ze'ev, 1990). 5  ￿  107 cpm of [~SS]methionine-labeled pro- 
teins were separated by 2-D gel electrophoresis and transferred to nitrocel- 
lulose by electroblotting. The radioactive proteins were visualized by auto- 
radiography of the blot. The positions of the transfected and the endogenous 
vinculin on the 2-D gels were identified by immunoblotting with the broad- 
range  monoclonal  antivinculin antibody,  followed  by  alkaline phospha- 
tase-linked anti-mouse IgG (Promega-Biotec, Madison, WI). The levels of 
mouse and chicken vinculin, which were separated on the 2-D gels, were 
determined from the autoradiograms  of fluorographed 2-D gels using a 
laser densitometer and computerized analysis of the images with the QUEST 
software system as described (Garrels, 1989). About 50-100 random pro- 
tein spots of the 2-D autoradiograms of each gel were matched by the com- 
puter and used for normalizing the different gels. The quantitative determi- 
nation of the level of vinculin was performed  in such normalized gels. 
Quantitative immunoblotting was carried out using  t25I-goat  anti-mouse 
IgG as second antibody. 
For  cell  fractionation,  cells  grown  in  35-mm  diameter  dishes  were 
labeled overnight with [35S]methionine and extracted with a Triton X-100- 
containing buffer: 1 ml of buffer containing 50 mM of MES (N-Morpholino- 
ethane sulfonic acid) pH 6.1, 2.5 mM EGTA, 5 mM MgC12, and 0.5% Tri- 
ton X-100 was added to the culture dishes at room temperature for 2 min. 
The Triton X-100-soluble fraction was removed and the insoluble fraction, 
enriched in membrane-cytoskeletal complexes (Ben-Ze'ev et al.,  1979) and 
adhesion plaques (Ball et al.,  1986), was scraped into 1 ml of the same 
buffer. Equal volumes of the two fractions were analyzed by PAGE, followed 
by immunoblotting with the broad-range antivinculin antibody. The blots 
were exposed to X-ray film to detect the total protein pattern. Cells were 
also labeled with [35S]methionine for 3 h and equal volumes of the Triton- 
soluble and -insoluble fractions were immunoprecipitated with antichicken 
vinculin antibody and the immunoprecipitates analyzed by polyacrylamide 
gel electrophoresis. 
Northern Blot Analysis 
Total RNA was extracted by the guanidinium thiocyanate method (Chirgwin 
et al.,  1979). Northern blots containing 20 #g per lane of total RNA were 
hybridized (sequentially) with different cDNA probes, which were labeled 
with 32P-dCrP by the random priming technique (Feinberg and Vogelstein, 
1983), as described (Ben-Ze'ev et al.,  1990). The following cDNAs were 
used: a mouse vinculin eDNA (Ben-Ze'ev et al., 1990), a human full-length 
c~-actinin eDNA obtained from D. Kwiatkowski (Harvard Medical School, 
Boston, MA) (Youssoufian et al., 1990), and a 1-kb mouse talin eDNA iso- 
lated in our lab by screening a eDNA library from 3T3-442A preadipocytes 
in Xgtl0 (obtained from B. Spiegelman, Harvard Medical School), with a 
partial chicken talin eDNA obtained from M. Beckerle (University of Utah, 
Salt Lake City, UT). The 1-kb mouse talin eDNA used corresponds to the 
COOH-terminal  332 amino acids of mouse talin. 
Tumorigenicity and Metastatic A bility Assays 
SVT2 cells were injected subcutaneously into syngeneic Balb/c mice (106 
or 5  ￿  106 cells per animal). The appearance and size of tumors and sur- 
vival time were examined daily. The ASML cells were injected into the foot- 
pad of syngeneic BDX rats (I0  ~ and 5  ￿  105 cells per animal), as described 
(Matzku et al.,  1983), and their survival was monitored. Rats were killed 
between 40 and 60 d after injection and the lymph nodes (inguinal and para- 
aortic), as well as the lung tissue, were examined. ASML cells were also 
injected into nude mice, with 105 and 106 cells per animal. 
Results 
Decreased Expression of Vinculin in 
SV-40-transformed 373 and in the Spontaneous 
Pancreatic ASML Adenocarcinoma 
The levels of vinculin expression were determined in two tu- 
mor cell lines; an SV-40-transformed Balb/c 3T3 line and in 
the ASML adenocarcinoma (Fig.  1).  In the SVT2 cell line 
The Journal of Cell Biology, Volume 119,  1992  428 Figure L Levels of vinculin expression in 3'1"3, SVT2, and ASML cells. Cell cultures were labeled for 20 h with 100/~C/ml of [35S]methi- 
onine and equal amounts of radioactive total cell protein were separated by 2-D gel electrophoresis and transferred to nitrocellulose. The 
pattern of total cell proteins was visualized by exposing the blots to X-ray films (,4, C, E). The blots were incubated with a broad-range 
antivinculin antibody followed by alkaline phosphatase-bound  anti-mouse  IgG (B, D, F). (G) Total RNA was extracted from 3T3 and 
ASML cells and equal amounts of RNA were separated on agarose gel, blotted onto nitrocellulose, and hybridized sequentially with mouse 
vinculin eDNA, human c~-actinin  eDNA, and mouse talin eDNA. (,4 and B) 3T3; (C and D) ASML; (E and F) SVT2. a, actin; v, vinculin. 
(Fig. 1, Eand F), vinculin content was reduced over fourfold 
when compared to control Balblc 3T3 cells (Fig.  1, A and 
B), as determined by computerized densitometry of the 2-D 
gels (Fig. 1, A and E). In the spontaneous rat pancreatic ade- 
nocarcinoma ASML cell line, the synthesis of vinculin was 
undetectable (Fig. 1 C), in agreement with a previous report 
(Raz et al.,  1986).  The immunoblot assay,  using a  broad- 
range antivinculin antibody, was negative in these ceils (Fig. 
1 D), and Northern blot analysis confirmed that while the lev- 
els of two adhesion plaque components, talin and c~-actinin, 
were comparable to those in Balb/c 3T3, no detectable vin- 
culin RNA could be demonstrated in the ASML cell line 
R~lr~guez Fermfndez et aL Tumor Suppression by Vinculin Transfection  429 Figure 2. Levels of vinculin expressed in transfected  SVT2 and ASML cells.  Nontransfected 3T3 cells (B and G), chicken vinculin-trans- 
fected ASML cells (C and H), chicken vinculin-transfected SVT2 cells (D and I), and neo  r control SVT2 cells (E and J) were labeled 
for 20 h with [3sS]methionkne. Total cell protein lysates were separated by 2-D gel electrophoresis and blotted onto nitrocellulose.  (B-E) 
Autoradiography of the blots. (G-J) Immunodetection of vinculin on the same blots with a broad range antivinculin  antibody. Individual 
chicken vinculin-transfected clones of ASML (.4, lanes 1-5) and SVT2 (F, lanes 1-6) were labeled for 3 h with 200 t~C/ml of [~S$]methio- 
nine, and 5  ￿  106 cpm of total cell protein were used for immunoprecipitation with an antibody specific for chicken vinculin from each 
clone. (A, lane 1, C and H) clone B  12; (,4, lane 2) clone B 42; (A, lane 3) clone C 62; (A, lane 4) clone B 31; (A, lane S) control, 
untransfected  ASML; (F, lane 1) control, untransfected  SVT2; (F, lane 2, E, and J) neo' SVT2 control; (F, lane 3) clone D 34; (F, lane 
4) clone D 41; (F, lane 5) clone D 43; (F, lane 6, D and I) clone D 44. cv, chicken vinculin; my, mouse vinculin. 
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Different Vinculin Levels 
Vinculin level* 
Clone  Chicken  Mouse  Tumor incidence  Growth in agar 
%  % 
3T3  0  750  0/6  (0)  <0.01 
neo 1  0  ND  6/6 (100)  11.0 -!- 0.8 
neo 3  0  140  6/6 (100)  13.3 :t: 1.0 
SVT2  0  135  6/6 (I00)  12.3 + 0.5 
D34  344  170  1/6  (16)  5.7 +  1.0 
D43  105  ND  5/6  (83)  ND 
D41  80  ND  5/6  (83)  ND 
D44  670  160  0/6  (0)  3.6 +  1.5 
* The levels of chicken and mouse vinculin were determined by quantitative 
computerized analysis of 2-D gels from [3SSlmethionine-labeled  total  cell ly- 
sates. The numbers represent arbitrary O.D.  units. 
ND, not done. 
(Fig.  1 G).  Southern blot analysis of genomic DNA from 
ASML cells using a mouse vinculin eDNA probe, did not 
reveal an apparent rearrangement of the vinculin gene in 
these cells (results not shown). 
Transfection  of  SVT2 and ASML Lines with 
Chicken Vinculin 
To study the effect of vinculin on the behavior of SVT2 and 
ASML cells, the two cell lines were cotransfected with a full- 
length chicken vinculin eDNA (Bendori et al.,  1989) and 
with the neomycin acetyl transferase gene (neo  r) conferring 
resistance to the aminoglycoside G418.  Resistant colonies 
were selected and screened by quantitative immunoprecipi- 
tation with an antibody that selectively recognizes chicken 
but not rodent vinculin (Fig. 2 F, compare lanes I  and 2 to 
lanes 3 and 6). The levels of chicken vinculin expressed in 
different transfected clones of either ASML (Fig.  2 A) or 
SVT2 (Fig. 2 F) were highly variable. To estimate the con- 
tent of the exogenous vinculin, relative to the endogenous 
pool in  SVT2 cells,  total  [35S]methionine-labeled cell ly- 
sates of different transfected lines were examined by 2-D gel 
electrophoresis. The gels were electroblotted onto nitrocel- 
lulose paper and the total cellular protein pattern visualized 
by autoradiography (Fig. 2, B-E). The identity of the vincu- 
lin spots was confirmed by immunoblotting using a broad- 
range vinculin antibody (Fig. 2, G-J). The levels of chicken 
and mouse vinculin were determined by quantitative, com- 
puterized densitometry of the autoradiograms (Fig. 2, B-E), 
Figure 3. Organization of  vinculin and actin in SVT2 and 313 cells. (,4 and B) Cells grown on coverslips were fixed with paraformaldehyde, 
permeabilized with Triton X-100, and immunostained with a broad range antivinculin antibody followed  by rhodamine-labeled anti-mouse 
IgG. (C and D) Actin filaments were visualized with FITC-labeled phalloidin. (A and C) 3T3 cells; (B, D) SVT2 cells. Bar, 10/~m. 
Rodrfguez Fernandez et al. Tumor Suppression by Vinculin Transfection  431 Figure 4. Organization  of vincniin and actin in vinculin-transfected  SVT2 ceils. (A and B) Cells grown on coverslips were immunostained 
with an antibody specific for chicken vinculin, followed  by rhodamine-anti-mouse IgG. (C and D) Actin filaments  were stained with FITC- 
phalloidin. (A and C) Chicken vinculin-transfected SVT2 cells, clone D44; (B and D) 3I"3 cells. Bar, t0 t~m. 
aided by the fact that chicken vinculin has the same Mr as 
the mouse protein, but a more basic pI (Fig. 2, H and/, com- 
pare to G and H).  The intensity of the vinculin spots was 
determined after the density of ~100  random  spots was 
normalized on  the different 2-D  gels  by  a  computerized 
program. 
In '~,70 independent transfected SVT2 clones the levels of 
chicken vinculin varied between 10%  to over 400%  of the 
endogenous vinculin pool. For example, in the transfected 
clone D 44 (Fig. 2, D and I), the synthesis of the exogenous 
vinculin was fourfold  higher than that of  the endogenous vin- 
culin (Fig. 2, E and J), and thus comparable to that present 
in nontransformed Balb/c 3T3 cells (Table I). Similarly, in 
over 100 different  transfected ASML clones, from two differ- 
ent transfections, the levels of the exogenous vinculin varied 
from 5 to 250% (Fig. 2, C and H) compared to the vinculin 
levels in Balb/C 3T3 cells (Fig. 2, B and G). Analysis of sev- 
eral autoradiograms of SVT2 clones expressing different  lev- 
els of  the transfected chicken vinculin, showed no significant 
changes  in  the level  of the endogenous mouse  vinculin. 
There were small variations in the growth rate among differ- 
ent clones,  but these  were  not related  to  the amount of 
chicken vinculin expressed in the respective cells. 
Immunofluorescent Localization  of the Transfected 
Vinculin  in SVI2 and ASML Cells 
SVT2 ceils have a very poorly organized actin filament net- 
work (Fig.  3 D)  with small vinculin-containing adhesion 
plaques (Fig. 3 B), compared to control Balb/c 3T3 cells 
(Fig. 3, C and A, respectively). In the transfected SVT2 cells, 
the exogenous chicken vinculin was localized with a chicken 
vinculin-specific antibody not recognizing the endogenous 
mouse vinculin (Fig. 4 B). In SVT2 cells, it was found that 
regardless of its level of expression, the transfected chicken 
vinculin was associated with adhesion plaques (Fig. 4 A) at 
the termini of  actin filaments ~ig. 4 C), essentially indistin- 
guishable from the endogenous mouse vinculin (Fig. 3 B). 
Moreover, cells expressing high levels of exogenous vinculin 
displayed a more fiat morphology with focal contacts appar- 
ently larger than those of SV'I2 cells. In ASML cells which 
have a rounded shape and do not express detectable levels 
of vinculin, only a faint background staining was obtained 
with the broad-range antivineulin antibody (Fig.  5 B).  In 
vinculin-transfected  ASML cells the foreign vinculin was or- 
ganized in small patches located along the ventral cell sur- 
face (Fig. 5 A).  Electron microscopic examination of cell 
The Journal  of Cell Biology,  Volume 119, 1992  432 Figure 5. Organization of  vinculin and actin in vinculin-transfected ASML cells. (,4 and B) Cells grown on coverslips were fixed and sheared 
off  the substrate by a stream of PBS, before further permeabilization with Triton X-100. The cells were immunostained with a broad-range 
antivinculin antibody, followed by rhodamine-anti-mouse  IgG. (C and D) Actin was visualized with FITC-phalloidin.  (A and C) Chicken 
vinculin-transfected  ASML ceils, clone B12; (B and D) Untransfected ASML cells. Bar, 10 ~m. 
substrate contacts in control and vinculin-transfected ASML 
cells, revealed that while the gross morphology did not radi- 
cally change,  vinculin expression resulted in a  twofold in- 
crease in the  average cross-section length of these contact 
sites (data not shown). 
To further determine the relative levels of assembled (Tri- 
ton  X-100  insoluble)  versus  unassembled  (Triton  X-100- 
soluble) vinculin, the content of the protein in the two frac- 
tions was determined (Fig. 6). Quantitative immunoblot and 
immunoprecipitation analyses with equal volumes of these 
fractions were performed with the various cells, either using 
the  broad-range  antivinculin  antibody  (Fig.  6  A),  or  the 
chicken vinculin-specific antibody  (Fig.  6  C).  The segre- 
gation  of  mouse  vinculin  between  a  Triton-soluble  and 
-insoluble fraction in 3T3 cells (Fig. 6 A, lanes 1 and 2), and 
of the transfected chicken vinculin in SVT2 cells (Fig. 6 C, 
lanes 1 and 2) were very similar (70% Triton-soluble, 30% 
Triton-insoluble).  A  higher  proportion  of the  transfected 
chicken vinculin  was found in the Triton X-100-insoluble 
fraction of the ASML transfectants (45%)  (Fig. 6 A, lanes 
6 and 8,  and Fig.  6  C,  lane 4) as compared to SVT2 cells 
(Fig. 6 C, lane 2). The reason for this variation could result 
from differences in extractability of proteins in the different 
cell types. 
Tumorigenic Properties of Vinculin-transfected  SVT2 
and ASML Cells 
Motivated by the suppressed expression of vinculin in SVT2 
and ASML cells, we examined the effect of forced expression 
of vinculin on the transformed phenotype. SVT2 cells, neo  r 
clones,  as  well  as  several  transfected  clones  expressing 
different levels of chicken vinculin (Fig. 2 F), were injected 
subcutaneously  into  syngeneic  Balb/c  mice,  and  develop- 
ment  of tumors  was  examined  (Table  I).  Nontransfected 
SVT2 cells and the  neo  r control clones produced palpable 
tumors within 5-7 d after injection.  These tumors reached, 
in 2-3 wk, a size of 4-6 cm in diameter. In contrast, clones 
expressing high levels of vinculin (such as clone D 44; Ta- 
ble I) did not produce palpable tumors even 2  mo after in- 
jection,  at which time the SVT2 and neo  r injected animals 
had all developed tumors and died.  The suppressed ability 
to form tumors in syngeneic animals by the vinculin overex- 
pressing  cells was  also  reproduced  in  nude  mice injected 
with the various clones.  As can be seen in Table II, the ex- 
pression of exogenous vinculin did not lead to complete sup- 
pression of tumorigenicity, but both the rate of tumor devel- 
opment  and  the  size  of  the  tumors  were  significantly 
reduced. Since the shape of the tumors was rounded, the de- 
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detergent-soluble  and -insoluble fractions.  3T3 ceils (A, lanes I and 
2),  ASML cells  (,4, lanes 3 and 4),  vinculin-transfected  ASML 
clone B 12 (A, lanes 5 and 6), and clone B 31 (A, lanes  7and 8) 
were labeled  for 20 h  with  [3~S]methionine. The cells  were ex- 
tracted with Triton X-100 and the level of vinculin was determined 
in the Triton X-100 soluble-  (A, lanes  1, 3, 5,  7) and insoluble- 
fractions (A, lanes  2, 4,  6, 8) by immunoblotting with a broad- 
range antivinculin antibody. (B) The total protein pattern of  the blot 
shown in A was  visualized  by autoradiography.  (C)  SVT2 cells 
transfected  with vinculin (clone D 34) (lanes  1 and 2) and ASML 
transfected  with vinculin (clone B 12) (lanes 3 and 4) were labeled 
for 3 h with [35S]methionine and the levels of the transfected  vin- 
culin in the Triton X-100 soluble (lanes I and 3) and insoluble frac- 
tions (lanes 3 and 4) were determined by immunoprecipitation with 
a chicken vinculin-specific antibody. (C, lane 5) Precipitation with 
nonimmune mouse serum of total radioactive ASML clone B  12 
cell  extracts,  vinc, vinculin. 
crease  in  tumor mass  formed in  nude  mice injected  with 
clones expressing high levels of  the transgene (D 34 and D 44) 
was six- to eightfold, compared to untransfected SVT2 ceils. 
It is noteworthy that transfected clones expressing the foreign 
vinculin  at levels  below  those  of the  residual  endogenous 
protein,  were essentially  indistinguishable  in their tumori- 
genic ability from the control SVT2 cells in both syngeneic 
and nude mice. To further characterize the cellular changes 
induced by the vinculin transfection, we determined the abil- 
ity of the cells to grow in semi-solid medium. As previously 
shown (Shin et al., 1975), 3T3 cells cannot grow in agar gels, 
while SV-40-transformed 3"1"3 cells readily form colonies in 
agar. The results shown in Table I indicate that SVT2 clones 
expressing the highest levels of vinculin had a  significantly 
reduced ability to form colonies in soft agar. 
Similar effects induced by vinculin transfection were also 
noted in the malignant metastatic  ASML line.  The various 
transfectants  and the  parental  line  were injected  into syn- 
geneic  BDX  rats.  Cells  injected  into  the  footpad,  readily 
spread  through the lymphatic system and formed multiple 
lung metastases  which killed  the  animals  within  35-55  d 
(Fig. 7). ASML cells expressing the highest levels of  chicken 
vinculin (clones B  12 and A  25),  had a  dramatically  sup- 
pressed  ability to form metastatic  tumors  (Table  HI),  and 
consequently animal survival after injection with these cells 
was significantly prolonged (Fig. 7). Cells expressing low or 
moderate levels of the transgene (Fig.  8) formed tumors in 
the lymph nodes in proximity to the site of injection, but had 
a significantly reduced capacity to form lung metastases (Ta- 
ble HI). Interestingly,  we noticed that upon prolonged cul- 
ture in vitro, revertants can be obtained from the transfected 
ASML clones which originally expressed high levels of vin- 
culin (five such clones were obtained).  Examination of the 
tumorigenic properties of revertants showed that in addition 
to the loss of vinculin expression,  the ceils reverted to the 
highly malignant phenotype (Fig.  7  and Table III; clone B 
12  r).  In vinculin-transfected  ASML clones  isolated  from 
two  independent  transfections,  the  tumorigenic  ability  in 
nude mice and the ability to grow in soft agar were both di- 
Table II. Latency and Growth of Tumors in Nude Mice 
Tumor diameter after injection day (in cm)* 
Cell line  7 d  14 d  21 d  28 d 
3T3  0  0  0  0 
(0,  0, 0, 0)  (0, 0, 0, 0)  (0, 0, 0, 0)  (0, 0, 0, 0) 
SVT2  0.5  2.1  6.0 
(0.4,  0.6, 0.5)  (2.0,  2.2, 2.1)  (6.0,  6.5, 5.4) 
D 34  0.2  1.2  3.8 
(0, 0.3, 0.4)  (1.0,  1.2,  1.3)  (3.6,  4.0, 3.9) 
D 44  0.1  0.9  3.2 
(0, 0, 0.3)  (1.0,  1.0, 0.7)  (3.2,  3.0,  3.5) 
ASML  0.7  0.9  1.0  1.1 
(0.6,  0.7, 0.7)  (0.8,  0.9, 0.9)  (0.8,  1.1, 0.9)  (1.2,  1.1,  1.0) 
neo 4  0.7  0.9  1.0  1.1 
(0.8,  0.6, 0.7)  (0.9,  0.9, 0.8)  (0.9,  1.1, 0.9)  (1.1,  1.3,  1.0) 
A 25  0  0  0.3  0.8 
(0, 0, 0, 0)  (0, 0, 0, 0)  (0, 0, 0.4, 0.6)  (0.6,  1.0, 0.8, 0.7) 
B  12  0  0  0  0.3 
(0, 0, 0, 0)  (0, 0, 0, 0)  (0, 0, 0, 0)  (0, 0, 0.3, 0.6) 
* The size of tumors is expressed as the mean higher outer diameter. As the tumors were spherical in shape, the differences in tumor mass formed in animals 
by vinculin-transfected  cells and controls were much larger (for example, the tumor mass formed by injecting D 44 was about sevenfold smaller at 21 d than that 
formed by injecting SVT2 cells). Animals injected with D 34, D 44, and SVT2 cells were killed 21 d after injection. 
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Figure Z Rat survival after in- 
jection with ASML cells ex- 
pressing different chicken vin- 
culin levels. Groups of six rats 
were  injected in the  footpad 
with 5  x  105 cells of ASML 
clones expressing different lev- 
els  of  chicken vinculin. The sur- 
vival time of individual rats, 
in  days,  was  determined. 
(zx---zx) Untransfected ASML 
cells; (X----X) clone B  12 r; 
(I----I) clone B  12; (o----o) 
clone  B  31;  (e----e)  clone 
C  62.  For levels of vinculin 
and corresponding tumorige- 
nicity of these clones see Fig. 
2 A and Table III. 
minished in clones expressing the highest levels of vinculin 
(clones A 25 and B  12; Tables II and III). As the tumors were 
spherical, the decrease in tumor mass formed in nude mice 
injected with these cells was more extensive (six- to eight- 
fold) than the two- to threefold decrease in tumor diameter 
shown in Table II. 
Discussion 
The primary objective of this study was to assess the specific 
effect of vinculin on the tumorigenic phenotype. We chose 
to focus on vinculin owing to several indirect observations 
including: (a) the reduction in vinculin levels observed in 
several spontaneous and vitally-induced tumors (Raz et al., 
1986; this study); (b) the known effects of malignant trans- 
formation on cell adhesiveness in general, and in particular 
on cell-matrix and cell-cell adherens junctions (Ben-Ze'ev, 
1985; Raz and Ben-Ze'ev, 1987); and (c) the role of vinculin 
in the assembly and stabilization of adherens junctions and 
the associated cytoskeleton (Bendori  et al.,  1989;  Geiger 
Table IlL Metastatic Spread of BSp 73ASML Expressing Different Vinculin Levels 
Metastatic load at autopsy 
BSp73 ASML 
clone  Growth in agar  Vinculin level*  Tumor take  Lymph nodes  Lung 
%  % 
14  17.8  +  1.9  0  5/5  0  2.5-5.0~  5/5 Miliaryw 
neo 4  12.4  +  0.5  0  5/5  0  2.5-5.0  5/5 Miliary 
neo 5  ND  0  5t5  ~  2.5-5.0  5/5 Miliary 
A 25  1.4  +  0.5  100  3/5  0  0.5-1.0  1/5 4 nodules 
4/5 no metastases 
B  12  2.6  +  0.7  118  2/5  0  1.0-2.0  2/5 5-20 nodules 
3/5  no metastases 
B  12 r  ND  0  5/5  ~  2.5-5.0  5/5 Miliary 
C  13  ND  31  5/5  q) 1.0-2.0  3/5  Miliary 
2/5 no metastases 
C 34  ND  30  5/5  ~  0.5-1.0  2/5 Miliary 
3/5 4 nodules 
D 26  5.1  +  1.9  14  515  0  2.5-5.0  2/5 Miliary 
3/5 2-25 nodules 
D 37  ND  23  5/5  0  2.5-5.0  3/5 Miliary 
2/5 3 nodules 
A 34  ND  26  5/5  0  2.0-5,0  3/5 Miliary 
2/5  10-32 nodules 
B 51  ND  10  5/5  ~  2.5-5.0  315 Miliary 
2/5 9-25 nodules 
The table reflects the state at 50 d after injection. 
ND, not done. 
* The levels of vineulin were obtained  by quantitative  computerized scanning of the immunoblots  shown in Fig. 8. The level of vinculin in the B 12 clone was 
determined by comparing  immunoprecipitations  of clone A 25 and B 12 in an independent  experiment. 
* Mean tumor diameter in centimeters. 
! Miliary is >1,000 nodules. 
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sis and metastasis assays. Equal amounts of protein of total cells 
lysates were separated by gel electrophoresis and the level of  vincu- 
lib was determined by quantitative immunoblotting with a broad 
range  antivinculin  antibody  followed by  t2SI-anti-mouse IgG. 
(Lane 1) Clone A 25; (lane 2) clone A 34; (lane 3) clone B 12 r; 
(lane 4) clone B 51; (lane 5) clone C 13; (lane 6) clone C 34; (lane 
7) clone D 26; (lane 8) clone D 37; (lane 9) clone neo 4; (lane 10) 
clone neo 5. v, vinculin. 
and Ginsberg, 1991). The dilficulty, however, in the unequiv- 
ocal interpretation of these earlier observations, was that the 
causal  relationships  between  vinculin  expression,  or  its 
modulation, and the acquisition of the transformed pheno- 
type, has not been established. To directly address this issue 
we selected two tumor lines in which vinculin expression 
was low or abolished, and determined the effect of expres- 
sion of this single protein on tumorigenicity in vivo and on 
the transformed phenotype in culture. 
The results indicated that restoration of vinculin in these 
tumor cells to the normal, or near normal levels, led to the 
drastic suppression of the tumorigenic ability of the cells. In 
both cell types this effect correlated directly with the level 
of expression of the foreign vinculin and with the extent of 
cell adhesion in culture. It thus appears that vinculin can act 
as an effective  tumor suppressor in these malignant cell lines. 
To assess the significance of these findings it is essential to 
address  two  major  questions:  (a)  Is  the  observed  effect 
strictly unique for vinculin? (b) What might be the molecular 
and cellular mechanism responsible for tumor suppression 
by vinculin? 
As far as the specificity of  the effect  is concerned, we found 
that control neo  r clones, as well as clones expressing low 
levels of the transfected vinculin were essentially as tumori- 
genic as the parental cell line. In addition, revertants that lost 
the  expression  of  the  exogenous  vinculin,  regained  the 
tumorigenic properties.  Furthermore, when attempting to 
determine  whether  in  vivo there  was  a  selection for de- 
creased expression of vinculin from the injected cells,  we 
found that cell lines established from the metastatic nodules 
of animals  injected with  vinculin-transfected adenocarci- 
noma ceils showed, in several such lines, a decreased level 
of vinculin (data not shown). To exclude the possibility that 
high levels of the vector itself affect nonspecificaUy cell be- 
havior,  we  have carried out  Southern blot analyses.  The 
results indicated that a large copy number of the integrated 
transfected cDNA did not always correlate with high levels 
of expression of the transfected vinculin, and only the latter 
corresponded  to  the  suppression  of tumorigenic  activity 
(data not shown). The suppression of tumorigenicity was ob- 
served with the vinculin-transfected cells in both syngeneic 
and nude mice which have a compromised immune system, 
suggesting that immunological reactions are apparently not 
the cause for the effect  observed. This conclusion is also sup- 
ported by the fact that vinculin is a highly conserved protein 
(Price et al.,  1989;  Weller et al.,  1990;  Ben-Ze'ev et al., 
1990), and thus a poor immunogen, and being an intraceltu- 
lar  protein,  it  is  not  exposed  to  the  immune  system. 
Moreover, overexpression of another cellular protein, such 
as a mutant murine p53 cDNA which lacks the nuclear local- 
ization signals (Shaulsky et al.,  1991), had no effect on the 
tumorigenicity of SVT2 cells (data not shown).  It appears 
therefore that the observations reported in this study are in- 
deed attributable to the specific increase in the expression of 
the transfected vinculin. 
Another  concern  is  whether  the  phenotypic effect ob- 
served in the vinculin transfectants is due only to an increase 
in vinculin levels, or to the fact that the transfected protein 
is derived from a different species.  The choice of chicken 
vinculin for transfection was based on both the availability 
of the respective cDNA, and on the need for vinculin that 
may be distinguishable immunochemically.from the endoge- 
nous rodent protein.  While we cannot exclude qualitative 
differences between the chicken and rodent proteins, all the 
data obtained suggest that the two are functionally indistin- 
guishable. The chicken and mammalian vinculins both hu- 
man (Price et al.,  1989;  Weller et al.,  1990) and partial 
sequences of mouse (Ben-Ze'ev et al.,  1990) are highly ho- 
mologous (>95 %). Immunofluorescence studies have shown 
that the transfected vinculin is associated with cell-matrix 
adhesions in both cell types and the partitioning of the exog- 
enous vinculin between Triton X-100 soluble and insoluble 
fractions was identical to that of the endogenous protein. 
The mechanism whereby a  specific increase in vinculin 
level suppresses tumorigenicity is not clear. Since vinculin 
is considered a structural component of cell-cell and cell- 
extracellular matrix contacts, it is conceivable that it exerts 
its effect on tumorigenicity by affecting cell adhesion and/or 
motility. The immunofluorescence and electron microscopic 
results,  showing that the area of cell substrate contacts in- 
crease in SVT2 and ASML cells expressing high levels of the 
transfected vinculin, support this notion. The effect of vincu- 
lin on cell motility was also recently demonstrated in Balb/c 
3T3 cells, expressing chicken vinculin. It was shown that its 
transfection into 3T3 cells results in a significant reduction 
in the locomotory ability of the cells (Rodrfguez Fermindez 
et al., 1992). In view of the dynamic nature of focal contacts 
and cell-cell adhesion assembly (Kreis et al.,  1984), an in- 
crease in vinculin levels can lead, by promoting a coopera- 
tive assembly of focal contact proteins, to a shift in the equi- 
librium between the soluble and membrane-bound pools of 
these components, to form more and more stable focal con- 
tacts (Geiger et al.,  1990). This will result in an increased 
adhesion and reduced locomotion (Rodriguez Fern~indez et 
al., 1992), and thus may bring about a suppressive effect on 
the tumorigenic properties of the transformed cells. 
This notion is in line with recent studies which demon- 
strated that transfecting into mammalian cells, genes coding 
for individual microfilament-associated proteins may alter 
microfilament organization and cell movement. For exam- 
ple, transient transfection, or microinjection, of villin into 
The Journal of Cell Biology, Volume 119,  1992  436 mesenchymal cells caused the disruption of stress fibers and 
the formation of microvilli (Friedrich et al.,  1989;  Franck 
et al.,  1990).  Furthermore,  the chemotactic  migration of 
3T3 cells was significantly increased in cells overexpressing 
gelsolin by 25 % after transfection  with the respective cDNA 
(Cunningham et al., 1991).  It was suggested that overexpres- 
sion of gelsolin may impair the assembly of microfilaments 
and thus enhance cell migration. 
It is noteworthy,  that transfections  into transformed cells 
of contact-receptors, which are known to associate with the 
microfilament system through a vinculin-rich plaque, brought 
about similar effects on the tumorigenic phenotype of cells: 
Overexpression of either the fibronectin receptor (Giancotti 
and Ruoslahti, 1990), or E-cadherin (Vleminckx et al., 1991; 
Frixen et al., 1991; Novarro et al., 1991), resulted in the sup- 
pression of the malignant phenotype. Moreover, in the highly 
metastatic ASML cells studied here, another adhesion mole- 
cule, the CIM4 hyaluronate receptor, shows a different splic- 
ing pattern compared to the nonmet astatic counterpart clone, 
Bsp73AS.  Transfection  of the ASML form of CD44 into the 
latter cell line was sufficient to confer a highly metastatic 
phenotype on them (G/Jnthert et al., 1991). The present study 
demonstrated that, in addition to contact receptors, modula- 
tions in the expression of a cytoplasmic component of ad- 
herens junctions are capable of effectively suppressing the 
tumorigenic behavior of cells. 
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